Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | CA7 | P43166 | 1/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.63 |
| ▸ | MME | P08473 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28855894 | 0.90 | ALDH1A1 (0.62) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL11877345 | 0.89 | HSD17B10 (0.74) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL11659676 | 0.88 | ALDH1A1 (0.61) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL11869914 | 0.87 | HSD17B10 (0.71) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL20353846 | 0.87 | HDAC8 (0.58) | HSD17B10TSHRMMEACEMEN1 | |
| SCHEMBL11515231 | 0.87 | HDAC8 (0.58) | HSD17B10TSHRMMEACEMEN1 | |
| SCHEMBL31290862 | 0.86 | MME (0.59) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL10067641 | 0.86 | MME (0.59) | HSD17B10TSHRCA1CA2CA7 | |
| SCHEMBL12205972 | 0.85 | MME (0.63) | HSD17B10CA1CA2CA7CA14 | |
| SCHEMBL18456226 | 0.85 | MME (0.63) | HSD17B10CA1CA2CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011084492-A1 | TRASH BAG WITH MALODOR CONTROL | THE GLAD PRODUCTS COMPANY (US) | 2011-07-14 | — | — | WO | claimed |
| EP-1029032-B1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2004-03-03 | — | — | EP | claimed |
| CN-109561680-B | Small molecule modulators of pantothenate kinase | 圣朱德儿童研究医院 | 2021-07-13 | — | — | CN | disclosed |
| CN-111787939-A | Methods of treating CASTOR-associated diseases | 圣朱德儿童研究医院有限公司 | 2020-10-16 | — | — | CN | disclosed |
| US-10640461-B2 | Heterodimers of glutamic acid | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2020-05-05 | — | — | US | disclosed |
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-9814722-B2 | Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2017-11-14 | — | — | US | disclosed |
| EP-2160445-B1 | Method for preparing non-textile polymer article | INVISTA TECHNOLOGIES SARL (CH) | 2017-03-22 | — | — | EP | disclosed |
| US-9328190-B2 | Non-textile polymer compositions and methods | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-05-03 | — | — | US | disclosed |
| US-20140357730-A1 | NON-TEXTILE POLYMER COMPOSITIONS AND METHODS | INVISTA North America S.à r.l. (US) | 2014-12-04 | — | — | US | disclosed |
| US-8048843-B2 | Fabric care compositions | INVISTA North America S.à.r.l. (US) | 2011-11-01 | — | — | US | disclosed |
| US-6713410-B1 | DEPOSITING A PERFUME MIXTURE WHICH PREFERENTIALLY DEPOSIT ON SPANDEX FIBERS AND IS RETAINED BETTER THAN ON OTHER TEXTILE FIBERS; WASHING; DEODORANT | E.I. DU PONT DE NEMOURS AND CO. | 2004-03-30 | — | — | US | disclosed |
| EP-1029032-B1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2004-03-03 | — | — | EP | disclosed |
| US-6465420-B1 | YARN OR FABRIC COMPRISING COTTON AND SPANDEX FIBRES, HAVING A PERFUME COMPOSITION DEPOSITED ON THE SAID YARN OR FABRIC | QUEST INTERNATIONAL B.V. (NL) | 2002-10-15 | — | — | US | disclosed |
| EP-1029032-A1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2000-08-23 | — | — | EP | disclosed |
| EP-1023480-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-1021160-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL NEDERLAND BV (NL) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999019452-A1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX® CONTAINING FABRICS | UNILEVER PLC (GB) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999019553-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999018926-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL B.V. (NL) | 1999-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | HSD17B10 890/4885TSHR 1396/4885CA1 2430/4885 |
| US-10640461-B2 | Heterodimers of glutamic acid | DDO, GLUL, ASNS | HSD17B10 585/4885TSHR 1266/4885CA1 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.